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Background: As the strongest antagonist of the platelet activating factor, ginkgolide B (GB) possesses anti-ischemic,
anti-oxidant and anti-convulsant properties, and it is used for the treatment of thrombosis in clinical practice. Till
now, GB is usually obtained from extraction of Ginkgo biloba leaves through column chromatography with an
extremely low yield and high cost, which can not meet clinical requirement. Therefore, it is urgent to find a new
method to prepare GB.
Results: In the current study, we studied the ability and mechanism to transform multi-component ginkgolide
into GB by Coprinus comatus in order to enhance the GB yield. Except for ginkgolide A (GA) and GB, all the other
ginkgolides in the extract were transformed by the strain. In the case of culture medium containing 20 g/L glucose,
the transformation product was identified as 12% GA and 88% GB by high performance liquid chromatography-Mass
spectrometry (HPLC-MS), two stage mass spectrometry (MS/MS) and nuclear magnetic resonance (NMR). Partial GA was
also transformed into GB according to the yield (76%) and the content of GA in the raw ginkgolide (28.5%). Glucose
was the key factor to transform ginkgolides. When glucose concentration in medium was higher than 40 g/L, all
ginkgolides were transformed into the GB. Proteomic analysis showed that C. comatus transformed ginkgolide into
GB by producing 5 aldo/keto reductases and catalases, and enhancing the metabolism of glucose, including
Embden-Meyerhof pathway (EMP), hexose monophophate pathway (HMP) and tricarboxylic acid (TCA).
Conclusions: C. comatus could transform ginkgolides into GB when the medium contained 40 g/L glucose. When
the strain transformed ginkgolides, the glucose metabolism was enhanced and the strain synthesized more aldo/
keto reductases and catalases. Our current study laid the groundwork for industrial production of GB.
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The extracts of Ginkgo biloba leaves (EGB) possess anti-
ischemic [1-3], anti-oxidant [4-6] and anti-convulsant prop-
erties [7]. A great deal of evidence supports that the
bioactive components of EGB, including the terpene trilac-
tones (TTLs) and flavonoids, have significant therapeutic
effects on age-related physical and mental deterioration as
well as cerebral vascular insufficiency, such as Alzheimer’s
and cardiovascular diseases [8-10]. TTLs consist of
ginkgolide A (GA), ginkgolide B (GB), ginkgolide C
(GC), ginkgolide J (GJ) (Figure 1) and bilobalide (BB)* Correspondence: zhangtamei@163.com
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unless otherwise stated.[11]. As the main bioactive constituents of EGB, TTLs
impart broad spectrum of pharmacological activities to
plants.
Among TTLs, GB has many pharmacological functions,
including anti-inflammatory, anti-tumor and ischemia-
reperfusion protection effects, and it has long been used
to treat central nervous system’s diseases, such as degen-
erative dementia and neurosensory disorders [12]. GB is
the strongest antagonist of the platelet activating factor
and used for the treatment of thrombosis in clinical prac-
tice [13,14]. However, the chemosynthesis of GB is very
difficult due to its unique structure, and the yield of GB
from EGB by chromatographic separation remains very
low. Different methods have been reported to improve GB
preparation [15-19], but they are all difficult to apply into
industrial production.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The structure of ginkgolide (G). GA: R1 = R2 = H, R3 = OH;
GB: R1 = R3 = OH, R2 = H; GC: R1 = R2 = R3 = OH; GJ: R1 = H, R2 = R3 =
OH; GM: R1 = R2 = OH, R3 = H.
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structures of complex natural products [20,21]. Bio-
transformation reaction has many advantages, such as
high regio- and stereo-selectivity; and mild reaction
conditions compared with chemical synthetic methods
[21,22]. Till now, many novel chemicals have been ob-
tained from the monomers of natural compounds by
this transformation approach, including flavonoids [23],
terpenoides [24], saponins [25] and alkanes [26]. Few
studies reported that one type of natural compound is
synchronously transformed by one specific strain. In
our previous studies, we proved that the edible and me-
dicinal fungi can enhance biological functions of herbs
through bio-transformation [27-30]. However, very lim-
ited information is available on how these edible and
medicinal fungi transform the components of herbs. In
order to explore its underlying mechanism, we com-
pared the different edible and medicinal fungi, including
Lentinus edodes, Agaricus bisporus, Coprinus comatus,
Ganoderma lucidum, Hericium erinaceus, Pleurotus
ostreatus, Pleurotus eryngii, Boletus edulis and Cordy-
ceps sinensis, and components of herbs, including flavo-
noids, terpenoids, alkaloids, anthraquinones and so on.
We found that many edible and medicinal could trans-
form natural components of herbs; especially C. coma-
tus could transform ginkgolide.
In the present study, we separated the transformation
products of total ginkgolide by Coprinus comatus UJS03
through extraction and recrystallization. Moreover, we
analyzed the structure of its individual components by
comparing the retention time of high performance
liquid chromatography (HPLC), nuclear magnetic res-
onance (NMR), infra-red spectrum (IR spectrum) and
mass spectrum (MS) with the corresponding spectra of
their standard substances. Taken together, this is the
first study reporting that one type of compounds wassynchronously converted into a simple compound by
one specific strain through bio-transformation.Methods
Microorganisms, media and culture conditions
A culture of C. comatus UJS03 was kindly provided by
Anhui Bioscience & Technology Co., Ltd. The stock cul-
ture was maintained on potato dextrose agar (PDA)
slants at 25°C for 9 days and then stored at 4°C. Total
ginkgolide, composed of GA 28.50%, GB 21.26%, GC
24.15%, GM 8.69%, GJ 11.12% and BB 6.28%, was pur-
chased from Xuzhou Kangruilai Bio-production Co.,
Ltd. (Xuzhou, China). The standards of GA and GB
were obtained from Chinese Food & Drug Inspection
Institute.
The medium applied in the transformation experi-
ments was prepared using distilled water and composed
of following components: glucose 20 g/L, corn powder
15 g/L, wheat bran 5 g/L, KH2PO4 2 g/L, MgSO4•7H2O
3 g/L, yeast extract 2 g/L and corn steep powder 5 g/L.
A 250-mL flask containing 60 mL medium was inocu-
lated by punching out 5 mm of the agar slant culture
with a self-designed cutter. The seed culture was grown
in a rotary shaker at 150 rpm and 25°C for 7 days. Sub-
sequently, 10 mL seed culture was inoculated into other
250-mL flasks containing similar medium and 0.5% total
ginkgolide, which were incubated under the same condi-
tions for 7 days. The broth was used to extract ginkgo-
lide. The biomass was used in proteomics analysis, and
the biomass without ginkgolide supplementation served
as the control in proteomic analysis.Isolation and purification of transformed ginkgolide
products
The broth and mycelium were separated through fil-
tration after 168 h of incubation. The mycelia was
dried at 80°C until a constant weight and then ex-
tracted at 80°C using 10 volumes of ethanol (v/w) for
three times. The obtained extracts as well as the fil-
trate were combined and dried in rotary-evaporator
under vacuum. The dried extract was dissolved using
10 volumes of ethyl acetate (v/w) at the room
temperature. The resulting solution was filtrated, and
the filtrate was washed by 3% NaHCO3 for three times
and then concentrated to dry. The residual was dis-
solved with 10 volumes of ethanol. The solution was
precipitated for 6 h by adding three volumes of dis-
tilled water (v/v). The precipitate was dissolved in
small amount of ethanol and recrystallized at -20°C for
6 h. The crystal was obtained through filtration,
washed with distilled water and then dried under the
infrared ray.
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Analysis of HPLC
HPLC analysis was performed on a Water Xbridge BEH C-
18 column (2.5 μm, 3.0 × 100 mm) using high pressure bin-
ary pump, Waters 996 diode array detector and Agilent
1200 Series auto-sampler. The elution was obtained with a
gradient of methanol (70%) and water (30%) at a flow rate
of 0.2 mL/min. The HPLC system was coupled with a
Agilent three-stage quadrupole mass spectrometry 6400
ion trap mass spectrometer (USA) operated in the mode of
full-scan negative ion electrospray ionization (ESI) (m/z
500-800). MS parameters were optimized to maximum
sensitivity as follows: ESI, negative polarity ionization; spray
voltages: 4.0 kV; heating capillary temperature: 275°C;
sheath gas (N2) flow: 30 Arb; Aux/sweep gas (N2); flow rate:
50 Arb.
Analysis of NMR and mass spectra
The 1H and 13C NMR spectra were determined using the
Bruker Avance III 500 spectrometer instrument. High-
resolution mass spectra were recorded on an LCQ-DECA
ion trap spectrometer (ThermoFisher, USA) using ESI in
negative polarity ionization.
Comparative proteomic analysis of C. comatus in response
to ginkgolide challenge
Frozen protein extraction
Frozen C. comatus mycelia (5 g) cultured in above-
mentioned medium with or without ginkgolide supple-
mentation were finely powdered in liquid nitrogen and
homogenized in ice-cold homogenizing buffer, containing
1.05 mol L−1 sucrose, 60 mmol L−1 Tris, 10 mmol L−1
ethylene glycol bis (2-aminoethyl) tetraacetic acid (EGTA),
1 mmol L−1 phenylmethanesulfonyl fluoride (PMSF),
1 mmol L−1 dithiothreitol (DTT) and 1% (v/v) Triton
X-100, pH 8.35. The homogenate was centrifuged
at 5,000 × g for 15 min at room temperature, and
the supernatant was collected and centrifuged again.
The supernatant was the protein extracts and stored
at -80°C for isoelectric focusing (IEF). The concentra-
tions of the protein extracts were determined by the
Bradford method [31].
Two-dimensional electrophoresis (DE)
The sample aliquots containing 1,500 μg proteins were
mixed with fresh rehydration buffer, consisting of 9 mol/L
urea, 4% 3-[(3-Cholanidopropyl)dimethylammonio]-1-pro-
panesulfonate, 1% DTT, 1% immobilized pH gradient (IPG
buffer) (GE Healthcare) and trace amount of bromophenol
blue, to a total volume of 450 μL. Samples were placed into
the strip holder (GE Healthcare, 24 cm, pH = 3-10, NL)
after the drystrips were obtained from -20°C freezer and
placed at room temperature for 10 min. IEF was performed
on an IPGhor IEF System (GE Healthcare). Parameters forIEF were set as follows: temperature: 20°C; 50 μA per strip;
rehydration at 50 V for 12 h (step), 500 V for 1 h (step),
1,000 V for 1 h (step), 10,000 V for 1 h (gradient), 10,000 V
for 11 h (step).
The strips were gotten from the strip holder, and the
redundant oil and protein solution were absorbed by
filter paper. The strips were incubated in equilibration
buffer 1, containing 6 mol/L urea, 30% glycerol, 2%
sodium dodecyl sulphate (SDS), 50 mM Tris-HCl
(pH 8.8), 1% DTT and trace amount of bromophenol
blue, for 15 min and then in equilibration buffer 2, con-
taining 6 mol/L urea, 30% glycerol, 2% SDS, 50 mM
Tris-HCl (pH 8.8), 2.5% Iodoacetamide and trace
amount of bromophenol blue, for 15 min. The strip was
then removed and rinsed with SDS electrophoresis buf-
fer (25 mmol/L Tris, 192 mmol/L glycine, 0.1%SDS) for
10 sec. After melted, the sealing solution (25 mmol/L
Tris, 192 mmol/L glycine, 0.1% SDS, 0.5% agarose) was
added to the surface of the SDS-PAGE gel (12% SDS gel
solution: 12% acrylamide, 0.32% N N’-methylenebisacry-
lamide, 0.375 mol/L pH 8.8, Tris-HCL, 0.1% SDS, 0.05%
ammonium persulphate, 0.05% N,N,N’,N’-Tetramethy-
lethyl –enediamine (TEMED)), and the strip was laid
across the top of the gel to make sure that the strip
could be flushed with the gel. After the sealing solution
was solidified, the gel was then moved to the electro-
phoresis apparatus for electrophoresis with parameters
as follows. The equipment was Ettan-DALT-Six system;
the temperature was at 15°C; gel running time was
45 min at 100 V and then 6-8 h at 200 V.
Protein staining and analysis of 2-D gels
After the electrophoresis, the gel was stained with
Coomassie brilliant blue (CBB) according to Candia-
no’s protocol [32]. All gel images were processed by
three steps, spot detection, volumetric quantification
and matching, using Pdquest 8.0 software. The dif-
ferences in protein content between treatment and
control groups were determined as the fold ratio. Spots
of ≥2 fold or ≤ 0.5 fold thresholds with a p value of less
than 0.05 were excised from the gels, washed with
double-distilled water and then transferred to sterilized
Eppendorf tubes.
In-gel protein digestion and identification by matrixassisted
laser desorption/ionization time-of-flight (MALDITOF/TOF)
The different protein spots were destained with 25 mmol/L
NH4HCO3 and 50% acetonitrile (ACN) at room tem-
perature for 30 min, and then they were sequentially dehy-
drated in 50% acetonitrile for 30 min and 100% acetonitrile
for 30 min. After removing 100% ACN, the proteins were
digested with 0.02 μg/μL trypsin (Promega, USA) at 37°C
overnight (about 16 h). After hydrolysis, the supernatants
were transferred into another tube. The residual gel was
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acid (TFA), 67% ACN) at 37°C for 30 min and then centri-
fuged for 5 min. The obtained supernatant was combined,
completely dried and re-suspended in 5 μL 0.1% TFA.
Subsequently, it was mixed with equal volume of matrix
consisting of a saturated solution of α-cyano-4-hydroxy-
trans-cinnamic acid in 50% ACN, 0.1% TFA. Then 1 μL
mixture was spotted on a stainless steel sample target
plate. Peptide MS and MS/MS were performed on an ABI
5800 MALDI-TOF/TOF Plus mass spectrometer (Applied
Biosystems, Foster City, USA). Data were acquired in a
positive MS reflector using a CalMix5 standard to cali-
brate the instrument (ABI4800 Calibration Mixture). Both
the MS and MS/MS data were integrated and processed
by using the GPS Explorer V3.6 software (Applied Biosys-
tems, USA) with default parameters. Based on combined
MS and MS/MS spectra, proteins were successfully
identified based on 95% or higher confidence interval
of their scores in the MASCOT V2.3 search engine
(Matrix Science Ltd., London, U.K.) according to fol-
lowing parameters: NCB Inr-Funji database; trypsin as
the digestion enzyme; one missed cleavage site; fixed
modifications of Carbamidomethyl (C); partial modifi-
cations of Acetyl (Protein N-term), Deamidated (NQ),
Dioxidation (W), Oxidation (M); 100 ppm for precursor
ion tolerance and 0.5 Da for fragment ion tolerance.
Results and discussion
The yield and analysis of the components of transformation
products
Through bio-transformation of the total ginkgolide by C.
comatus, the yield of GB was 76% and much higher
compared with those obtained using other extraction
methods because the theoretical maximum GB yield of
conventional methods could not be higher than the GB
content in the raw materials (26.12%). The control cul-
ture of C. comatus without ginkgolide supplementation
did not produce GB. The result showed that C. comatus
could not synthesize GB from scratch. Therefore, it sug-
gested that C. comatus could transform other ginkgolides
into the GB. To verify our deduction, all components of
the product were analyzed with HPLC-MS, MS-MS and
NMR spectra, respectively.
Analysis of HPLC-MS
The LC-MS/MS method was first applied to analyze the
components of bio-transformation product. Its total ion
chromatograms (in Figure 2A) only exhibited two peaks
of which retention times and molecular ion peaks at m/z
were consistent with GA (5.745 min, 407, Figure 2B)
and GB (6.463 min, 423, Figure 2C), respectively, and
the peaks of GC, GM, GJ and BB were not detected.
Therefore, these two peaks were deduced as the GA and
GB, and other compounds were transformed or degradedby C. comatus. However, the production yield (76%) and
total content of GA (28.50%) and GB (21.26%) in raw
materials exhibited that the GC, GM and GJ were trans-
formed into GA or GB if the two components in the
production were GA and GB. Based on the external
standard method and area of peaks, the content of GA
and GB was 12% and 88%, respectively.
Analysis of MS/MS
In order to further identify these two peaks, MS/MS was
used to compare the mass spectra of the product and
standards of GA and GB. The results showed that in the
negative mode, the two molecular ion peaks [M-H]- of
sample were at m/z 407 and 423 in a mass spectrometry
(Figure 3A and B), and their fragment spectra at m/z
351 and 333 (Figure 3A) and 367, 345 (Figure 3B) were
similar to those of the standard GA and GB, respectively.
These results further proved that transformation products
were GA and GB. In the spectra of MS/MS, the disappear-
ance of molecular ion peak at m/z 325 demonstrated that
BB was degraded or transformed by C. comatus. No detec-
tion of other molecular ion peaks also exhibited that the
product did not contain other impurities other than GA
and GB.
Analysis of the 1H, 13C NMR and the heteronuclear singular
quantum correlation (HSQC) spectra
Analysis of the 1H, 13C NMR and the HSQC spectra
(Figure 3C and D) showed the 1H-1H COSY and 1H-13C
HSQC spectra of the product. The signal assignments
for 1H NMR and 13C NMR spectrometry in Figure 3C
and D were shown in Tables 1 and 2. Table 2 reveals that
two components of the product contained the same
number of carbons and possessed the similar structure.
The disappearance of 7-OH group (in Table 1) exhibited
that the product did not contain GC, GM and GJ, which
were transformed by C. comatu. The 1H, 13C NMR, and
the COSY, HSQC spectra of two components in the
product were consistent with the spectra of the standard
GA and GB (Figure 3C and D). The significant differ-
ence of main carbon’s chemical shift between GA and
GB was found between C-1, C-5 and C-9 of two compo-
nents. The chemical shift of hydrogen atom of the corre-
sponding carbon atoms exhibited significant differences
(Table 1). These differences were caused by the hydroxyl
group in C-1 of GB. The content of GA and GB was
12% and 88%, respectively, based on the integral quanti-
fication of 10-hydroxyl groups in the 1H-1H COSY spec-
tra. Moreover, our data showed that no other 1H NMR
and 13C spectrometry belonged to GA and GB in the
1H-1H COSY and 1H-13C HSQC spectra, confirming
that no other impurities existed in the production.
In summary, the product contained two components
of GA and GB, and their contents were 12% and 88%,
Figure 2 HPLC-MS chromatograms of the transformation product. (A) HPLC analysis of the product; (B) ESI-MS (-) MS spectrum of the
retention time at 5.586 min; (C) ESI-MS (-) MS spectrum of the retention time at 6.387 min.
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to GB, and other ginkgolides were all transformed into
GB, the theoretical maximum content should be 72.5%
because the GA content in raw materials was 28.5% and
other ginkgolides content in raw materials was less than
the true content of production (88%). Based on the facts,
it was believed that the partial GA was also transformed
into GB or degraded.
The mechanism of ginkgolide transformation into GB by
C. comatus
To disclose the mechanism that C. comatus transformed
ginkgolides, the proteins difference of C. comatus bio-
mass between transforming and un-transforming gink-
golide was analyzed. Comparative analysis of 2-DE gels
between the medium with and without ginkgolide sup-
plementation showed that the 24 proteins spots were
differently expressed in response of the ginkgolide chal-
lenge (Figure 4A and B). Among these different proteins,
six proteins were down-regulated and 18 proteins were
up-regulated. The down-regulated proteins included
chaperonin GroL (3711), succinate-CoA ligase (2710),
NADP-binding protein (4701), hypothetical proteinHETIRDRAFT-413641 (4816), V-type ATPase (3909) and
an unknown protein (4817). The up-regulated proteins
included 6-phosphogluconate dehydrogenase (6108), glyc-
eraldehyde 3-phosphate dehydrogenase (6302), glucose-
6-phosphate isomerase (8002), malate dehydrogenase
(6303), 5 aldo/keto reductases (6201, 5119, 5113, 6103,
1007), catalase (7820), UDP-glucose 4-epimerase (6402),
cobalamin-independent methionine synthase (7204), acet-
amidase/formamidase (2803), cyclophilin (7203), 3 hypo-
thetical protein (5513, 4513, 5114) and an unknown
protein (5008).
It is known that glucose-6-phosphate isomerase and
glyceraldehyde 3-phosphate dehydrogenase are the rate
limiting enzymes of Embden-Meyerhof pathway (EMP),
6-phosphogluconate dehydrogenase is the rate limiting
enzyme of hexose monophophate pathway (HMP), and
malate dehydrogenase is the rate limiting enzyme of
tricarboxylic acid (TCA) cycle. Our data suggested that
HMP, EMP and TCA involved into glucose metabolism
were enhanced in the response of ginkgolide challenge.
In the HMP, 1 mol glucose-6-phosphate is converted
into the 6-phosphogluconate and ribulose-5-phsphate by
two steps of dehydrogenation reaction, which produces
Figure 3 MS/MS and NMR chromatograms of product. (A) ESI-MS (-) MS spectrum of GA (m/z 408); (B) ESI-MS (-) MS spectrum of GB (m/z 423);
(C) the 1H-1H COSY spectra; (D) the 1H-13C HSQC spectra.
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tide phosphate (NADPH) used as the reducing powder
(NADPH). Moreover, 1 mol glucose is converted into
1 mol glucose 6-phosphate, 1 mol fructose 6-phosphate
is converted into 1 mol fructose-1,6-biphosphate by two
steps of phosphorylation of EMP and consume 2
adenosine-triphosphate (ATP). However, 1 mol fructose-
1,6-biphosphate can form glyceraldehydes 3-phosphate
and dihydroxyacetone phosphate that can synthesize 4ATP and 2 NADH by EMP. Therefore, 1 mol glucose
can produce 2 mol ATP, 2 mol NADH and 2 mol pyru-
vate by EMP. In addition, 1 mol pyruvate is oxidized
into CO2 and H2O by TCA pathway, creating 4 mol
reduced nicotinamide adenine dinucleotide (NADH),
1 mol reduced flavin adenine dinucleotide (FADH) and
1 mol GTP, which is equal to 15 ATPs. Therefore, 1 mol
glucose can produce 38 mol ATP by EMP and TCA
cycle [33]. The increased activities of these key enzymes,
Table 1 Assignment of the 1H-1H correlation signals found in the two-dimension COSY spectra of the transformed
production
Chemical shift (ppm) J (Hz) Number of proton Assignmenta 1H-1H COSY
7.46 d/5.0 1 10-OH (B) H10 (B)
6.82 d/5.2 0.15 10-OH (A) H10 (A)
6.47 s 1 3-OH (B)
6.38 s 0.15 3-OH (A)
6.07 s 1 H12 (B)
6.02 s 0.15 H12 (A)
5.30 d/4.0 1 H6 (B) H7a, H7b (B)
5.02 d/5.0 1 H10 (B) 10-OH (B)
4.92 m 1 1-OH (B) H1 (B)
1.14 H6, H10 (A) H7, 10-OH (A)
4.83 dd/7.2,8.0 0.15 H2 (A) H1a, H1b (A)
4.64 d/7.4 1 H2 (B) H1 (B)
4.04 dd/3.0,7.4 1 H1 (B) H2, 1-OH (B)
2.93 q/7.2 0.15 H14 (A) H16 (A)
2.83 q/7.1 1 H14 (B) H16 (B)
2.75 dd/7.2,15.2 0.15 H1a (A) H1b, H2 (A)
2.15 m 1 H7a (B) H7b, H8 (B)
2.02 m 1.14 H7 (A) H8 (A)
1.96 m 1 H7b (B) H6, H7a, H8 (B)
1.81 dd/8.0,15.2 0.15 H1b (A) H1a, H2 (A)
1.72 m 1 H8 (B) H7a, H7b (B)
0.15 H8 (A) H7 (A)
1.11 m 3 H16 (B) H14 (B)
0.51 H16 (A) H14 (A)
1.03 s 9 H18, H19, H20 (B)
1.53 H18, H19, H20 (A)
a(A): H assigned ginkgolide A; (B): H assigned ginkgolide B.
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3-phosphate dehydrogenase of EMP, 6-phosphogluconate
dehydrogenase of HMP and malate dehydrogenase of
TCA, suggested that the metabolism of EMP, HMP and
TCA was enhanced to provide NADPH and ATP to trans-
form multi-component ginkolide.
UDP-glucose 4-epimerase catalyzes a freely reversible
reaction between UDP-galactose and UDP-glucose, and
it facilitates the utilization of galactose in the wheat bran
of the medium. Cobalamin-independent methionine syn-
thase catalyzes the synthesis of methionine by transfer-
ring a methyl group from methyltetrahydrofolate to
homocysteine. Amidases are enzymes that catalyze the
hydrolysis of amide compounds to their corresponding
carboxylic acid and ammonia [34]. Formamidase (KFase)
(EC 3.5.1.9) is a key enzyme in the metabolic sequence
of tryptophan [33]. Their activity increase hinted that
the catabolism of protein was enhanced to provide theATP to transformation of ginkgolides. Succinate-CoA
ligase, a mitochondrial matrix enzyme, catalyzes the
reversible conversion of succinyl-COA and ADP or GDP
to succinate and ATP or GTP, and at least the ADP-
forming enzyme is part of the Krebs cycle. The down-
regulation of succinate-CoA ligase suggested that more
succinyl-COA was involved into TCA and TCA.
In contrast to the molecular structure of GC, GA, GB,
GJ and GM, it is found that the difference between them
depends on the different number and sites of the hydroxyl
groups. GA contains one hydroxyl group on the R3 site,
GB, GJ and GM all contain two hydroxyl groups on the
R1 and R3 sites, 1 and R3, R2 and R3 sites, respectively.
GC contains three hydroxyl groups on the R1, R2 and R3
sites. Therefore, if GA, GC, GM, and GJ are all trans-
formed into GA, the H on the R1 site of GA and GJ and
on the R3 site of GM are oxidized into OH, the OH on
the R2 site of the GC, GJ and GM are reduced into H.
Table 2 Assignment of the 1H - 13C correlation signals found in the two-dimension HSQC and HMBC of transformed
production
Chemical shift (ppm) DEPT Numbeer of Carbon Assignmenta HSQC HMBC
176.60 C 0.15 C15 (A) H2, H14, H16 (A)
176.39 C 1 C15 (B) H2, H14, H16 (B)
174.34 C 0.15 C11 (A) H10, H12 (A)
173.95 C 1 C11 (B) H10, H12 (B)
170.80 C 0.15 C13 (B)
170.28 C 1 C13 (B) H6 (B)
109.61 CH 1 C12 (B) H12 (B) H8, 3-OH (B)
109.51 CH 0.15 C12 (A) H8 (A)
100.26 C 0.15 C4 (A) H1a, H12, 3-OH (A)
98.45 C 1 C4 (B) H12, H14, 3-OH (B)
91.81 CH 1 C2 (B) H2 (B) H1, H3 (B)
87.70 CH 0.15 C2 (A) H2 (A) H1b (A)
86.08 CH 0.15 C6 (A) H6 (A)
85.14 C 0.15 C3 (A) H1a, H1b (A)
82.90 C 1 C3 (B) H2, H14, H16, 3-OH (B)
78.60 CH 1 C6 (B) H6 (B) H7 (B)
73.76 CH 1 C1 (B) H1 (B) H2, H16 (B)
71.69 C 1 C9 (B)
69.05 CH 1 C10 (B) H10 (B) H8, 10-OH (B)
68.74 CH 0.15 C10 (A) H10 (A)
68.06 C 0.15 C9 (A)
67.42 C 1 C5 (B) H6, H7, H10, 10-OH (B)
66.83 C 0.15 C5 (A) H1a, H1b (A)
48.56 CH 1 C8 (B) H8 (B) H7, H10, H12 (B)
H18, H19, H20 (B)
48.53 CH 0.15 C8 (A) H8 (A)
41.52 CH 1 C14 (B) H14 (B) H2, H3, H16 (B)
40.44 CH 0.15 C14 (A) H14 (A)
36.59 CH2 1 C7 (B) H7 (B) H8 (B)
36.31 CH2 0.15 C7 (A) H7 (A)
35.94 CH2 0.15 C1 (A) H1a, H1b (A)
31.97 C 1 C17 (B) H8, H18, H19, H20 (B)
31.95 C 0.15 C17 (A)
28.87 CH3 3 C18, C19, C20 (B) H18. H19, H20 H8 (B)
0.51 C18, C19, C20 (A) H18, H19, H20 H8 (A)
8.19 CH3 0.15 C16 (A) H16 (A)
7.85 CH3 1 C16 (B) H16 (B) H14 (B)
a(A): C assigned ginkgolide A; (B): C assigned ginkgolide B.
Ding et al. BMC Biotechnology  (2015) 15:17 Page 8 of 11Namely, there may be some oxidants and reductases in
the internal mycelia. Catalase is an induced enzymes and
converts hydrogen peroxide into harmless water and oxy-
gen similar to superoxide dismutase to prevent free radical
damage to the body. The up-regulation of catalase exhib-
ited an increase of the H2O2content. H2O2 might oxidze Hon the R3-site of GM and R1-site of GA and GJ into to
OH. Aldo/keto reductases play a key role in reducing the
OH on the R2 site of the GC, GJ and GM into the H
group. The H of these reduction reactions all comes from
the NADPH, whereas the energy comes from ATP. There-



























Figure 4 The 2D-gel analysis of C. comatus proteins extracted from mycelia. (A) grown in media not supplied ginkgolide; (B) grown in
media supplied ginkgolide.
Ding et al. BMC Biotechnology  (2015) 15:17 Page 9 of 11transformation experiment was increased, the slight
amount of GA in production might be fully transformed to
GB. To validate the deduction, the effect on transformation
of C. comatus to ginkgolides was compared at different
glucose concentrations, including 20 g/L, 30 g/L, 40 g/L,
50 g/L and 60 g/L, and we found that all ginkgolides,
including ginkgolides A, were fully transformed into
ginkgolides B when the glucose concentration in the
medium was higher than 40 g/L.
Cyclophilins display the enzymatic activity of a peptidyl-
prolyl isomerase (PPIase) [35,36], which catalyzes the cis
to trans conversion of proline-containing peptides and
facilitates protein folding. Protein folding in vivo is assisted
by a set of proteins collectively known as molecular chap-
erones, which help successfully proteins fold to their
native structures in the crowded environment of the livingcells [37-39]. The up-regulation of cyclophilins and down-
regulation of chaperones showed that the higher structure
of some enzymes and proteins was changed to convert
ginkgolides into GB.
V-ATPases from in all eukaryotic cells are a type of
highly conserved protein and consist of more than 10 dif-
ferent subunits in two functional domains. A membrane-
associated domain (V0) forms the proton channel, and a
soluble catalytic domain (V1) is involved in ATP hydrolysis
[40,41]. NADP-binding protein is a type of NADP
dependent protein, and it controls the rate of oxidative
phosphorylation reaction by involving in dehydrogen-
ation reaction. The down-regulation of these enzymes
and proteins exhibited that the ATP applied into proton
channel was decreased to provide ATP and NADH to
transform ginkgolide.
Ding et al. BMC Biotechnology  (2015) 15:17 Page 10 of 11Conclusions
We developed a method to transform ginkgolide into GB
by strain C. comatus. The product yield reached 76%, and
was much higher compared with conventional extraction.
Analysis of LC-MS, MS/MS and NMR revealed that the
transformation product included GB and GA when the
medium only contained 20 g/L glucose, and their content
was 88% and 12%, respectively. When the glucose concen-
tration in medium was higher than 40 g/L, all ginkgolides
were transformed into GB by C. comatus. Proteomic ana-
lysis further confirmed that the C. comatus transformed
the ginkgolide, and the reduction power and energy for
the bio-transformation were provided by NADPH and
ATP, which were obtained in the process of glucose me-
tabolism and synthesis. The method laid the found for bio-
transformation of active components in herbs.
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